Trends in intravenous magnesium use and outcomes for status asthmaticus in children's hospitals from 2010 to 2017

Vineeta Mittal, Matt Hall, James Antoon, Jessica Gold, Chen Kenyon, Kavita Parikh, Rustin Morse, Ricardo Quinonez, Ronald J. Teufel, Samir S. Shah

Research output: Contribution to journalArticlepeer-review

10 Scopus citations

Abstract

Intravenous (IV) magnesium is used as an adjunct therapy in management of status asthmaticus with a goal of reducing intubation rate. A recent review suggests that IV magnesium use in status asthmaticus reduces admission rates. This is contrary to the observation of practicing emergency room physicians. The goal of this study was to assess trends in IV magnesium use for status asthmaticus in US children's hospitals over 8 years through a retrospective analysis of children younger than 18 years using the Pediatric Health Information System database. Outcomes were IV magnesium use, inpatient and intensive care unit admission rate, geometric mean length of stay, and 7-day all-cause readmission rate. IV magnesium use for asthma hospitalization more than doubled over 8 years (17% vs. 36%; P <.001). Yearly trends were not significantly associated with hospital or intensive care unit admission rate or 7-day all-cause readmissions, although length of stay was reduced (P <.001).

Original languageEnglish (US)
Pages (from-to)403-406
Number of pages4
JournalJournal of hospital medicine
Volume15
Issue number7
DOIs
StatePublished - Jul 2020

ASJC Scopus subject areas

  • Internal Medicine
  • Leadership and Management
  • Fundamentals and skills
  • Health Policy
  • Care Planning
  • Assessment and Diagnosis

Fingerprint

Dive into the research topics of 'Trends in intravenous magnesium use and outcomes for status asthmaticus in children's hospitals from 2010 to 2017'. Together they form a unique fingerprint.

Cite this